awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35162123-DFCAE20A-4EA9-45C3-9845-9D8F7F0DB081
Q35162123-DFCAE20A-4EA9-45C3-9845-9D8F7F0DB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35162123-DFCAE20A-4EA9-45C3-9845-9D8F7F0DB081
Comparison of bevacizumab and ranibizumab in age-related macular degeneration: a systematic review and meta-analysis.
P2860
Q35162123-DFCAE20A-4EA9-45C3-9845-9D8F7F0DB081
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35162123-DFCAE20A-4EA9-45C3-9845-9D8F7F0DB081
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
70a2d8783f5ae20ffe6e50baf609cadc68e4273e
P2860
Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.